Cardiovascular & Hematological Disorders-Drug Targets

(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)


Garry X. Shen
University of Manitoba
Winnipeg, MB


Become EABM
Become Reviewer

May Oxygen-Ozone Therapy Improves Cardiovascular Disorders?

Volume:9   Issue: 2
Pp: 78-85
Velio Bocci, Valter Travagli and Iacopo Zanardi
DOI: 10.2174/187152909788488681

Red Cell Glycolytic Enzyme Disorders Caused by Mutations: An Update

Volume:9   Issue: 2
Pp: 95-106
Fernando Climent, Feliu Roset, Ada Repiso and Pablo Perez de la Ossa
DOI: 10.2174/187152909788488636

Expressions of eNOS3 and Ve-Cadherin in Microvascular Endothelium at 7-Day of Reperfused Acute Myocardial Infarction

Volume:9   Issue: 2
Pp: 107-117
Sheng Kang, Yue-jin Yang, Qing-zhi Wang, Yue Li, Yi Tian and Yu-tong Cheng
DOI: 10.2174/187152909788488663

The Important New Drug Target in Cardiovascular Medicine – the Vascular Glycocalyx

Volume:9   Issue: 2
Pp: 118-123
Angela J. Drake-Holland and Mark I. Noble
DOI: 10.2174/187152909788488708

A Simple Technique to Establish a Long-Term Adenovirus Mediated Gene Transfer to the Heart of Newborn Mice

Volume:9   Issue: 2
Pp: 136-140
Marina Jerebtsova, Xuehai Ye and Patricio E. Ray
DOI: 10.2174/187152909788488645

Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis

Volume:9   Issue: 2
Pp: 141-148
Alberto Lazaro, Gloria Alvarez-Llamas, Julio Gallego-Delgado, Fernando de la Cuesta, Julio Osende, Ma Eugenia G. Barderas and Fernando Vivanco
DOI: 10.2174/187152909788488672

Intravascular Targeting of a New Anticoagulant Heparin Compound

Volume:9   Issue: 2
Pp: 149-158
Maria C. Van Walderveen, Leslie R. Berry and Anthony K. C. Chan
DOI: 10.2174/187152909788488654